Skip to main content
Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · IEX Real-Time Price · USD
21.50
+0.51 (2.43%)
At close: Apr 26, 2024, 4:00 PM
20.57
-0.93 (-4.33%)
After-hours: Apr 26, 2024, 7:38 PM EDT

Dianthus Therapeutics Revenue

In the year 2023, Dianthus Therapeutics had annual revenue of $2.83M, a decrease of -55.96%. Revenue in the quarter ending December 31, 2023 was $457.00K, a -61.11% decrease year-over-year.

Revenue (ttm)
$2.83M
Revenue Growth
-55.96%
P/S Ratio
223.27
Revenue / Employee
$53,321
Employees
53
Market Cap
630.96M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.83M-3.59M-55.96%
Dec 31, 20226.42M--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Embecta 1.12B
The Pennant Group 544.89M
Treace Medical Concepts 187.12M
SI-BONE 138.89M
Y-mAbs Therapeutics 84.82M
Revenue Rankings

DNTH News

More News